<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01329237</url>
  </required_header>
  <id_info>
    <org_study_id>COMPARE-II-Imaging</org_study_id>
    <nct_id>NCT01329237</nct_id>
  </id_info>
  <brief_title>COMPARE-II- Vasomotion and Imaging Substudy</brief_title>
  <acronym>COMPARE-IT</acronym>
  <official_title>Comparison of the Everolimus Eluting (XIENCE-V® or PROMUS® Stent) With the Biolimus A9 Eluting NOBORI® Stent in All-comers: a Randomized Open Label Study The COMPARE II Trial Imaging and Vasomotion Substudy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Freiburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare strut coverage and neointimal thickness between
      everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14
      months after stent implantation and to determine the coronary endothelial function after
      everolimus eluting (XIENCE-V® or PROMUS® stent) and biolimus A9 eluting NOBORI Stent 14
      months after stent implantation by using supine bicycle exercise testing to assess coronary
      vasomotor response to exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DESIGN:

      Imaging and vasomotion Substudy:

      50 consecutive patients enrolled in the COMPARE II trial at the University of Fribourg
      Medical Center will undergo follow-up re-angiography 14 months after index procedure with
      assessment of Optical coherence tomography (OCT) and vasomotion testing.

      ENDPOINT SUBSTUDY (all at 14 months):

      Primary endpoint imaging: percentage of uncovered stent struts per lesion and mean neointimal
      thickness assessed by OCT.

      vasomotion: coronary vasomotion assessed with quantitative coronary angiography at rest and
      during supine bicycle exercise.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of uncovered stent struts per lesion assessed by OCT</measure>
    <time_frame>within 14 months after percutaneous coronary stent implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>coronary vasomotor function</measure>
    <time_frame>within 14 months after stentimplantation</time_frame>
    <description>coronary vasomotion assessed with quantitative coronary angiography at rest and during supine bicycle exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean neointimal thickness assessed by OCT</measure>
    <time_frame>within 14 months after stent implantation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>dynamic physical exercise OCT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>dynamic physical exercise and optical coherence tomography imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>dynamic physical exercise and OCT imaging</intervention_name>
    <description>supine dynamic physical exercise during coronary angiography and optical coherence tomography OCT imaging of the coronary stent</description>
    <arm_group_label>dynamic physical exercise OCT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient enrolled in the COMPARE II trial with successful stent implantation and
             absence of binary restenosis or severe progression of coronary artery disease at 14
             months follow-up.

          -  Patient consent to undergo a non-scheduled follow- up angiography with imaging study
             and bicycle exercise testing

        Exclusion Criteria:

          1. Inability to provide informed consent

          2. Inability to perform a supine bicycle exercise stress test

          3. Binary in stent restenosis of the target vessel

          4. Acute Coronary Syndrome, Acute Myocardial Infarction

          5. Patients with stent thrombosis following the index procedure

          6. Female of childbearing potential ( age ≤ 50 years and last menstruation within the
             last 12 months ), who did not undergo tubal ligation, ovariectomy or hysterectomy

          7. Known intolerance to heparin, contrast material

          8. History of bleeding diathesis or known coagulopathy

          9. Age ≥ 80 years

         10. Hemodynamic instability

         11. Renal failure (creatinine clearance ≤ 40 ml/min)

         12. OCT / IVUS technically not feasible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario Togni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Fribourg, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stéphane Cook, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Fribourg, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Christophe Stauffer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Cantonal HFR, Fribourg, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Jacques Goy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Cantonal HFR, Fribourg, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gérard Baeriswyl, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hopital Cantonal HFR, Fribourg, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pieter C Smits, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maasstad Ziekenhuis, Rotterdam, The Netherlands</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mario Togni, MD</last_name>
    <phone>++41-26-426-8130</phone>
    <email>mario.togni@unifr.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Cook, MD</last_name>
    <phone>++41-26-426-8130</phone>
    <email>stephane.cook@unifr.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopital Cantonal HFR</name>
      <address>
        <city>Fribourg</city>
        <zip>1708</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Schafroth, RN</last_name>
      <phone>++41-26-426-8507</phone>
      <email>schrafrotho@h-fr.ch</email>
    </contact>
    <investigator>
      <last_name>Mario Togni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2011</study_first_submitted>
  <study_first_submitted_qc>April 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2011</study_first_posted>
  <last_update_submitted>April 4, 2011</last_update_submitted>
  <last_update_submitted_qc>April 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>TOGNI Mario/Professor of Medicine</name_title>
    <organization>University of Fribourg Medical Center</organization>
  </responsible_party>
  <keyword>drug-eluting stent</keyword>
  <keyword>coronary endothelial function</keyword>
  <keyword>coronary imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

